Trikafta 75 mg (Ivacaftor GRANULES) 75 MG

TRIKAFTA 75 MG granules contain ivacaftor, a medication used to treat cystic fibrosis. This oral formulation is designed for patients who require a specific dosage form.

Strength

75 MG

Manufacturer / TM Owner

VERTEX PHARMACEUTICALS (CANADA) INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

TRIKAFTA 75 MG granules are primarily used in the management of cystic fibrosis. Ivacaftor, the active ingredient, works to improve the function of a protein affected by this genetic condition. Patients may use this medication as part of a broader treatment plan to manage symptoms and improve respiratory function.

Side Effects

Common effects of TRIKAFTA 75 MG granules may include improvements in lung function and overall health for individuals with cystic fibrosis. Some users might experience gastrointestinal discomfort or other mild side effects. It is important to monitor for any adverse reactions and consult a healthcare provider if concerns arise.

Precautions & Warnings

TRIKAFTA 75 MG granules should be handled with care, ensuring proper storage and administration as directed. Patients should be aware of potential allergies to ivacaftor or any inactive ingredients. Regular medical check-ups are recommended to monitor the effectiveness and safety of the treatment.

Avoid Interactions

TRIKAFTA 75 MG granules may interact with certain medications, including those metabolized by the liver's CYP3A enzymes. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and other substances that affect liver function should be used with caution.

Frequently Asked Questions

TRIKAFTA 75 MG granules are used to manage cystic fibrosis by improving the function of a specific protein affected by the condition.

TRIKAFTA 75 MG granules are taken orally, typically mixed with a small amount of soft food or liquid. Follow the instructions provided by your healthcare provider.

Common side effects may include gastrointestinal discomfort and other mild reactions. Always consult a healthcare provider if you experience any adverse effects.

TRIKAFTA 75 MG may interact with certain medications, particularly those metabolized by the liver. Inform your healthcare provider about all medications you are taking.

TRIKAFTA 75 MG is designed for specific genetic mutations associated with cystic fibrosis. Consult a healthcare provider to determine if it is appropriate for your condition.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.